Thibaut Mongon Johnson & Johnson (JNJ) insider trading activity

JNJ Quotes by TradingView

Thibaut Mongon is Exec VP, WW Chair, Cons Health of JOHNSON & JOHNSON. Currently has a direct ownership of 65,915 shares of JNJ, which is worth approximately $10.9 Million. The most recent transaction as insider was on Feb 13, 2023, when has been sold 6,430 shares (Common Stock) at a price of $162.01 per share, resulting in proceeds of $1,041,724. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.9K
0% 3M change
0% 12M change
Total Value Held $10.9 Million

Thibaut Mongon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2023
SELL
Payment of exercise price or tax liability
$1,041,724 $162.01 p/Share
6,430 Reduced 8.89%
65,915 Common Stock
Feb 13 2023
BUY
Grant, award, or other acquisition
-
13,710 Added 15.93%
72,345 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$133,878 $162.08 p/Share
826 Reduced 1.39%
58,635 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
2,285 Added 3.7%
59,461 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$1,853,767 $108.77 p/Share
17,043 Added 22.96%
57,176 Common Stock
Nov 04 2022
SELL
Open market or private sale
$6,033,410 $171.18 p/Share
35,246 Reduced 46.76%
40,133 Common Stock
Nov 04 2022
BUY
Exercise of conversion of derivative security
$4,607,357 $130.72 p/Share
35,246 Added 31.86%
75,379 Common Stock
Mar 17 2022
SELL
Open market or private sale
$1,916,760 $176.27 p/Share
10,874 Reduced 14.56%
63,814 Common Stock
Mar 17 2022
SELL
Open market or private sale
$4,174,013 $176.26 p/Share
23,681 Reduced 37.11%
40,133 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$3,108,361 $100.97 p/Share
30,785 Added 29.19%
74,688 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$305,735 $165.89 p/Share
1,843 Reduced 4.03%
43,903 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
3,922 Added 7.9%
45,746 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$256,652 $168.85 p/Share
1,520 Reduced 3.51%
41,824 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
3,759 Added 7.98%
43,344 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$558,731 $165.55 p/Share
3,375 Reduced 7.86%
39,585 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
7,145 Added 14.26%
42,960 Common Stock
Feb 21 2020
SELL
Open market or private sale
$5,803,583 $147.96 p/Share
39,224 Reduced 52.27%
35,815 Common Stock
Feb 21 2020
BUY
Exercise of conversion of derivative security
$1,738,619 $90.44 p/Share
19,224 Added 20.39%
75,039 Common Stock
Feb 13 2020
SELL
Payment of exercise price or tax liability
$217,264 $150.46 p/Share
1,444 Reduced 2.52%
55,815 Common Stock
Feb 13 2020
BUY
Exercise of conversion of derivative security
-
3,692 Added 6.06%
57,259 Common Stock

Also insider at

KVUE
Kenvue Inc.
Chief Executive Officer
TM

Thibaut Mongon

Exec VP, WW Chair, Cons Health
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNJ